| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
,
MICHEL DAVID,
MAGUELONE G. FOREST,
HERVE BETUEL,
GEORGES HAUPTMAN,
JEAN ANDRE,
JEAN BERTRAND and
WALTER L. MILLER
INSERM U34 (Y.M., M.G.F., J.B.) and Pediatric Clinic, Hopital Debrousse (M.D., J.A.) 69322 Lyon Cedex 05
The Centre de Transfusion Sanguine (H.B.) 69342 Lyon Cedex 07
The Laboratoire de Recherches en Immunologie (G.H.) 67085 Strasbourg, France
The Department of Pediatrics and Metabolic Research Unit, University of California (Y.M., W.L.M.) San Francisco, California 94143
Address all correspondence and requests for reprints to: Walter L. Miller, M.D., Room 677-S, Pediatrics, University of California, San Francisco, California 94143.
Congenital adrenal hyperplasia (CAH) can be caused by a variety of defects in the functional gene encoding 21-hydroxylase (P450c21), which lies in the midst of the human leukocyte antigen (HLA) locus on chromosome 6. As a result, Mendelian genetics permit clinically distinct forms of CAH to be traced genetically by HLA and complement typing of family members. The recent cloning of probes for P450c21 now permits tracing of the affected gene directly.
A consanguineous family had three members affected with three clinically distinct forms of CAH. Two of these individuals had identical extended haplotypes, including nine HLA and complement loci. Despite this extensive identity, the patterns of genomic DNA fragments digested with endonuclease EcoRI and detected by a P450c21 cDNA probe differed greatly in these two individuals. Thus, the DNA diagnosis of allelic variation was much more sensitive than the HLA diagnosis.
Genomic DNA digested with endonuclease Taql and probed with P450c21 cDNA revealed the 3.2-kilobase (kb) band, which i s generally associated with the nonfunctional P450c21 A pseu-dogene, in all family members, and also revealed the 3.7-kb band associated with the functional P450c21 B gene in all family members except the severely affected index case. Probing of the same blots with a genomic probe also permitted examination of the adjacent downstream Taql fragments, showing retention of both the 2.4-kb (A pseudogene) and 2.5-kb (B gene) fragments. Similarly, BglII-digested genomic DNA from all individuals contained both the 12-kb (A pseudogene) and 11-kb (B gene) bands. These data indicate that the basis of 21-hydroxylase deficiency i n the index case was due to a homozygous gene conversion event and not to gene deletion. These results show that the DNA i n and around the 21-hydroxylase gene is genetically very active, so that the usual generalizations concerning linkage and inheritance may yield incorrect conclusions and diagnoses.
* This work was supported by INSERM U 34, INSERM CRE 843005, March of Dimes Grant 6-396, and NIH Grant DK-37922.
Supported by grants from la Fondation pour la Recherche Medicale and the Philippe Foundation.
Received July 13, 1988.
This article has been cited by other articles:
![]() |
R. Menassa, V. Tardy, F. Despert, C. Bouvattier-Morel, J. P. Brossier, M. Cartigny, and Y. Morel p.H62L, a Rare Mutation of the CYP21 Gene Identified in Two Forms of 21-Hydroxylase Deficiency J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1901 - 1908. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-H. Lee, S.-F. Chang, Y.-J. Lee, S. Raskin, S.-J. Lin, M.-C. Chao, F.-S. Lo, and C.-Y. Lin Deletion of the C4-CYP21 Repeat Module Leading to the Formation of a Chimeric CYP21P/CYP21 Gene in a 9.3-kb Fragment as a Cause of Steroid 21-Hydroxylase Deficiency Clin. Chem., February 1, 2003; 49(2): 319 - 322. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |